NCT07602192 Quantitative Chest CT and Multi-Omics to Distinguish Asthma From COPD and Predict Treatment Response
| NCT ID | NCT07602192 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Korea University Guro Hospital |
| Condition | Asthma (Diagnosis) |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-12-22 |
| Primary Completion | 2027-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-12-22 with a primary completion date of 2027-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to improve the diagnosis and treatment prediction of asthma and chronic obstructive pulmonary disease (COPD) by combining quantitative chest computed tomography (CT) imaging with multi-omics data. Adults with asthma or COPD will be enrolled and undergo routine clinical evaluations, pulmonary function tests, blood tests, and chest CT scans. Additional samples, such as sputum and microbiome specimens, may also be collected. No experimental drugs or devices will be administered as part of this study. Researchers will analyze CT imaging features together with clinical, laboratory, and biological data to better distinguish asthma from COPD and to identify factors that may predict treatment response. The findings are expected to contribute to more precise and personalized management of chronic airway diseases.
Eligibility Criteria
Inclusion Criteria: * Age ≥19 years * COPD group: post-bronchodilator FEV1/FVC \< 0.70 * Asthma group: clinically confirmed diagnosis of asthma by a physician * Able to provide voluntary written informed consent Exclusion Criteria: * Acute exacerbation or active lower respiratory tract infection (e.g., pneumonia) within the past 4 weeks * Pregnancy or breastfeeding * Inability to undergo chest CT (e.g., poor cooperation or severe medical condition) * Refusal to consent to study procedures
Contact & Investigator
Sang Hyuk Kim, MD
PRINCIPAL INVESTIGATOR
Korea University Guro Hospital
Frequently Asked Questions
Who can join the NCT07602192 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Asthma (Diagnosis). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07602192 currently recruiting?
Yes, NCT07602192 is actively recruiting participants. Contact the research team at gost702@korea.ac.kr for enrollment information.
Where is the NCT07602192 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT07602192 clinical trial?
NCT07602192 is sponsored by Korea University Guro Hospital. The principal investigator is Sang Hyuk Kim, MD at Korea University Guro Hospital. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.